Pain Meds and Cannabis Edibles: Leading Causes of Pediatric Poisonings in Wisconsin
Accidental cannabis edible poisoning children is an emerging pediatric health concern in Wisconsin. Edible cannabis products often resemble candy, increasing poisoning risks. Clinicians must counsel families on safe storage to prevent accidental…
No Driving Impairment Despite Residual THC Blood Levels – NORML
Detectable THC blood levels do not necessarily indicate driving impairment. This clinical evidence highlights the difference between residual THC presence and actual functional impairment. Clinicians should counsel patients accordingly for safer driving…
Cannabidiol for Fibromyalgia: Evidence-Based Clinical Trial Analysis
This article reviews cannabidiol clinical trials fibromyalgia to assess CBD's efficacy in pain reduction. Recent randomized controlled trials found no superiority of CBD over placebo. These findings guide clinicians on CBD use in fibromyalgia treatment.
Legal Home Cannabis Cultivation: Key Insights for Clinicians
This update covers legal home cannabis cultivation and its clinical relevance for patient access. Clinicians should understand evolving regulations and safety concerns. Labor safety in cannabis cultivation also remains a critical issue.
IRS Files First Response to Common Industry 280E Arguments
The IRS Section 280E tax deductions cannabis policy directly impacts cannabis business profitability and patient access. This response clarifies tax burdens on cannabis businesses. Clinicians should understand these tax implications when advising…
Why Medical Marijuana Evaluations Require a Doctor | MMJ Insights
Medical marijuana evaluations by licensed healthcare providers establish a clinical foundation for safe patient use by documenting medical history and potential drug interactions. These evaluations ensure cannabis recommendations are based on clinical…
New Research Suggests Cannabis May Improve Women’s Sexual Health
Emerging research highlights cannabis sexual health benefits for women, suggesting potential improvements in sexual function and intimacy. Clinicians should be aware of these findings to provide informed counseling. Understanding cannabis's role in…
DEA Scheduling Synthetic Drugs: March 12, 2026 Updates
The March 12, 2026 update covers DEA scheduling synthetic drugs and related regulatory affairs. This includes synthetic opioids and marijuana rescheduling proposals. Clinicians should note implications for controlled substances management.
Cannabinoids and PTSD: Clinical Research on Trauma Care
Cannabinoids and PTSD clinical research reveals trauma-focused treatments benefit patients using cannabis with co-occurring substance use disorders. Evidence suggests clinicians should not delay PTSD care based on cannabis use alone. This research…
Endocannabinoid System Clinical Research: Cannabis and Mental Health RCT
The Minder mobile mental health intervention was tested in a randomized controlled trial targeting university students. This digital tool aims to improve mental health and substance use outcomes during the critical college transition period. Results…